319,306 Shares of iShares U.S. Pharmaceuticals ETF $IHE Purchased by MinichMacGregor Wealth Management LLC

MinichMacGregor Wealth Management LLC acquired a new position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 319,306 shares of the company’s stock, valued at approximately $32,098,000. iShares U.S. Pharmaceuticals ETF accounts for 5.4% of MinichMacGregor Wealth Management LLC’s investment portfolio, making the stock its largest position.

Several other large investors also recently added to or reduced their stakes in the business. Valley Wealth Managers Inc. purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 3rd quarter worth $90,000. Cadent Capital Advisors LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 1,298.7% during the 3rd quarter. Cadent Capital Advisors LLC now owns 35,010 shares of the company’s stock valued at $3,519,000 after purchasing an additional 32,507 shares during the period. Congress Asset Management Co. purchased a new position in shares of iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $56,000. Tidal Investments LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth $3,716,000. Finally, Integrated Wealth Concepts LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the 2nd quarter worth $75,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA:IHE traded up $2.38 during trading on Wednesday, hitting $99.74. 357,889 shares of the company’s stock were exchanged, compared to its average volume of 165,532. The business’s 50-day simple moving average is $102.61 and its 200 day simple moving average is $96.34. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a 52-week low of $73.42 and a 52-week high of $108.66.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.